Anti-DDB-2 Rabbit Antibody [M14F11]

Catalog No.: F1449

打印

Biological Description

Specificity Anti-DDB-2 Rabbit Antibody [M14F11] detects endogenous levels of total DDB-2 protein.
Background DDB2 (Damage-specific DNA-binding protein 2) is a protein encoded by the human DDB2 gene located on chromosome 11p12-p11. It plays a vital role in the nucleotide excision repair (NER) pathway, where it recognizes and binds to UV-induced DNA lesions to initiate repair. DDB2 contains several key domains: a terminal seven-bladed WD40 β-propeller domain responsible for DNA interaction, a disordered N-terminal tail rich in lysine residues that serve as ubiquitination sites, and a helix-loop-helix motif (residues 101–136) that interacts with DDB1 to form the UV-DDB complex, essential for damaged DNA recognition. Upon UV damage recognition, DDB2 activates the Cullin 4-RING ubiquitin ligase complex (CRL4^DDB2^), which ubiquitinates histones, XPC, and DDB2 itself, promoting chromatin remodeling and efficient repair. DDB2 levels fluctuate throughout the cell cycle: they rise during mid-G1, peak at the G1/S boundary, and decline during S phase, reflecting its role in DNA damage response and cell cycle regulation. The expression of DDB2 is tightly regulated: its transcription is activated by p53 and TAp63γ, while reactive oxygen species and AP1 transcription factors also induce its expression in a p53-independent manner. Post-translational modifications, including ubiquitination, phosphorylation by p38 MAPK, poly(ADP-ribosylation), and SUMOylation, dynamically regulate DDB2’s stability, chromatin binding, and repair functions. Additionally, DDB2 affects cell cycle progression by degrading inhibitors like p27 and CDT2 and stabilizing CDT1, which contributes to DNA replication licensing. Dysregulation of DDB2 has been linked to carcinogenesis, and its expression levels are associated with sensitivity to chemoradiotherapy.

Usage Information

Application WB Dilution
WB
1:1000
Reactivity Human
Source Rabbit MW 43 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

References

  • https://pubmed.ncbi.nlm.nih.gov/25628365/
  • https://pubmed.ncbi.nlm.nih.gov/36190612/

Application Data